390 related articles for article (PubMed ID: 33271751)
1. Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach.
Saeed M; Saeed A; Alam MJ; Alreshidi M
Molecules; 2020 Dec; 25(23):. PubMed ID: 33271751
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
[TBL] [Abstract][Full Text] [Related]
4. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
Batool A; Bibi N; Amin F; Kamal MA
Eur J Pharmacol; 2021 Feb; 892():173779. PubMed ID: 33275961
[TBL] [Abstract][Full Text] [Related]
5. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
[TBL] [Abstract][Full Text] [Related]
6. Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach.
Motwalli O; Alazmi M
J Mol Model; 2021 May; 27(6):160. PubMed ID: 33963942
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
Shalayel MH; Al-Mazaideh GM; Aladaileh SH; Al-Swailmi FK; Al-Thiabat MG
Pak J Pharm Sci; 2020 Sep; 33(5):2179-2186. PubMed ID: 33824127
[TBL] [Abstract][Full Text] [Related]
8. Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies.
Kumar S; Sharma PP; Upadhyay C; Kempaiah P; Rathi B; Poonam
Methods; 2021 Nov; 195():44-56. PubMed ID: 33639316
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
Choi R; Zhou M; Shek R; Wilson JW; Tillery L; Craig JK; Salukhe IA; Hickson SE; Kumar N; James RM; Buchko GW; Wu R; Huff S; Nguyen TT; Hurst BL; Cherry S; Barrett LK; Hyde JL; Van Voorhis WC
PLoS One; 2021; 16(4):e0250019. PubMed ID: 33886614
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight.
Singh R; Bhardwaj VK; Purohit R
Cell Biochem Funct; 2022 Dec; 40(8):926-934. PubMed ID: 36203381
[TBL] [Abstract][Full Text] [Related]
11. Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.
Kim Y; Wower J; Maltseva N; Chang C; Jedrzejczak R; Wilamowski M; Kang S; Nicolaescu V; Randall G; Michalska K; Joachimiak A
Commun Biol; 2021 Feb; 4(1):193. PubMed ID: 33564093
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the hexamerization of SARS-CoV-2 endoribonuclease and modeling of RNA structures bound to the hexamer.
Tran DP; Taira Y; Ogawa T; Misu R; Miyazawa Y; Kitao A
Sci Rep; 2022 Mar; 12(1):3860. PubMed ID: 35264667
[TBL] [Abstract][Full Text] [Related]
13. Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL
Jade D; Ayyamperumal S; Tallapaneni V; Joghee Nanjan CM; Barge S; Mohan S; Nanjan MJ
Eur J Pharmacol; 2021 Jun; 901():174082. PubMed ID: 33823185
[TBL] [Abstract][Full Text] [Related]
14. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
Canal B; Fujisawa R; McClure AW; Deegan TD; Wu M; Ulferts R; Weissmann F; Drury LS; Bertolin AP; Zeng J; Beale R; Howell M; Labib K; Diffley JFX
Biochem J; 2021 Jul; 478(13):2465-2479. PubMed ID: 34198324
[TBL] [Abstract][Full Text] [Related]
15. An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2.
Sharma J; Kumar Bhardwaj V; Singh R; Rajendran V; Purohit R; Kumar S
Food Chem; 2021 Jun; 346():128933. PubMed ID: 33418408
[TBL] [Abstract][Full Text] [Related]
16. Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis.
Ibrahim IM; Elfiky AA; Fathy MM; Mahmoud SH; ElHefnawi M
Sci Rep; 2022 Aug; 12(1):13337. PubMed ID: 35922447
[TBL] [Abstract][Full Text] [Related]
17. New antiviral target revealed by the hexameric structure of mouse hepatitis virus nonstructural protein nsp15.
Xu X; Zhai Y; Sun F; Lou Z; Su D; Xu Y; Zhang R; Joachimiak A; Zhang XC; Bartlam M; Rao Z
J Virol; 2006 Aug; 80(16):7909-17. PubMed ID: 16873248
[TBL] [Abstract][Full Text] [Related]
18. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
Kumar S; Kashyap P; Chowdhury S; Kumar S; Panwar A; Kumar A
Phytomedicine; 2021 May; 85():153317. PubMed ID: 32943302
[TBL] [Abstract][Full Text] [Related]
19. Structural and Biochemical Characterization of Endoribonuclease Nsp15 Encoded by Middle East Respiratory Syndrome Coronavirus.
Zhang L; Li L; Yan L; Ming Z; Jia Z; Lou Z; Rao Z
J Virol; 2018 Nov; 92(22):. PubMed ID: 30135128
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.
Sixto-López Y; Martínez-Archundia M
J Comput Chem; 2021 May; 42(13):897-907. PubMed ID: 33713492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
